{"id":"NCT00365859","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)","officialTitle":"A 52-Week, Open-Label, Multicenter Study of the Safety and Tolerability of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents With Autistic Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09","primaryCompletion":"2009-06","completion":"2009-06","firstPosted":"2006-08-18","resultsPosted":"2010-01-25","lastUpdate":"2013-12-02"},"enrollment":330,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Autistic Disorder","Behavioral Symptoms"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["Abilify","BMS-337039"]}],"arms":[{"label":"De Novo","type":"EXPERIMENTAL"},{"label":"Rollover Placebo","type":"EXPERIMENTAL"},{"label":"Rollover Aripiprazole","type":"EXPERIMENTAL"}],"summary":"This study will provide long-term safety data for patients who are taking aripiprazole for up to 1 year. Most patients enrolled in this study will have participated in a short-term study with aripiprazole (CN138-178 \\[NCT00332241\\] or CN138-179 \\[NCT00337571\\]).","primaryOutcome":{"measure":"Number of Participants With Serious Adverse Events (SAEs), Treatment-Emergent Adverse Events (AEs), Deaths, AEs Leading to Discontinuation, Extra Pyramidal Syndrome (EPS)-Related AEs","timeFrame":"From Screening (up to 42 days prior to treatment start) through Week 52 (end of study) for SAEs; from Week 0 (Baseline) through Week 52 (End of Study) for AEs","effectByArm":[{"arm":"De Novo","deltaMin":0,"sd":null},{"arm":"Rollover Placebo","deltaMin":0,"sd":null},{"arm":"Rollover Aripiprazole","deltaMin":0,"sd":null},{"arm":"Total","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":55,"countries":["United States"]},"refs":{"pmids":["37811711","21813076","21663425"],"seeAlso":["http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx","http://www.cdc.gov/growthcharts/percentile_data_files.htm"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":86},"commonTop":["WEIGHT INCREASED","VOMITING","NASOPHARYNGITIS","INCREASED APPETITE","PYREXIA"]}}